Viewing Study NCT05145218


Ignite Creation Date: 2025-12-25 @ 4:55 AM
Ignite Modification Date: 2025-12-25 @ 4:55 AM
Study NCT ID: NCT05145218
Status: UNKNOWN
Last Update Posted: 2021-12-08
First Post: 2021-11-23
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus Paclitaxel as Weekly Treatment of Relapsed Platinum-resistant Ovarian Cancer
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module